412 related articles for article (PubMed ID: 15388461)
21. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
[TBL] [Abstract][Full Text] [Related]
22. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
24. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile typhlitis associated with cecal mucosal hyperplasia in Syrian hamsters.
Ryden EB; Lipman NS; Taylor NS; Rose R; Fox JG
Lab Anim Sci; 1991 Dec; 41(6):553-8. PubMed ID: 1667196
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
McVay CS; Rolfe RD
Antimicrob Agents Chemother; 2000 Sep; 44(9):2254-8. PubMed ID: 10952564
[TBL] [Abstract][Full Text] [Related]
27. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
[TBL] [Abstract][Full Text] [Related]
28. A mouse model of Clostridium difficile-associated disease.
Chen X; Katchar K; Goldsmith JD; Nanthakumar N; Cheknis A; Gerding DN; Kelly CP
Gastroenterology; 2008 Dec; 135(6):1984-92. PubMed ID: 18848941
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
Oldfield EC
Rev Gastroenterol Disord; 2004; 4(4):186-95. PubMed ID: 15580153
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile associated diarrhea: new rules for an old game.
Verma P; Makharia GK
Trop Gastroenterol; 2011; 32(1):15-24. PubMed ID: 21922851
[TBL] [Abstract][Full Text] [Related]
31. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
[TBL] [Abstract][Full Text] [Related]
33. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
[TBL] [Abstract][Full Text] [Related]
34. Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
Chang TW; Gorbach SL; Bartlett JG; Saginur R
Gastroenterology; 1980 Jun; 78(6):1584-6. PubMed ID: 7372074
[TBL] [Abstract][Full Text] [Related]
35. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
36. Colonization for the prevention of Clostridium difficile disease in hamsters.
Sambol SP; Merrigan MM; Tang JK; Johnson S; Gerding DN
J Infect Dis; 2002 Dec; 186(12):1781-9. PubMed ID: 12447764
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
38. The changing face of Clostridium difficile: what treatment options remain?
Shen EP; Surawicz CM
Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea.
Gorenek L; Dizer U; Besirbellioglu B; Eyigun CP; Hacibektasoglu A; Van Thiel DH
Hepatogastroenterology; 1999; 46(25):343-8. PubMed ID: 10228818
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
Aslam S; Hamill RJ; Musher DM
Lancet Infect Dis; 2005 Sep; 5(9):549-57. PubMed ID: 16122678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
